What was recalled
In a move aimed at maintaining the integrity of medical diagnostics, the U.S. Food and Drug Administration (FDA) announced on July 22, 2026, that Merge Healthcare, Inc. is recalling specific units of its Merge PACS and Merge OrthoPACS systems. These are not consumer electronics found in typical households; rather, they are sophisticated medical imaging diagnostic workstations designed for professional healthcare environments. The recall targets devices running software version V9.5, which can be identified by the Unique Device Identifier (UDI) code 00842000101239(10)9.5.0(11)260409. This specific versioning is critical because the issue lies within the software’s ability to process and display measurement data accurately.
The scope of this recall covers units that were distributed nationwide across the United States, with specific distribution patterns noted in the states of California, Florida, Kentucky, Nebraska, and Washington. It is important to understand that these workstations are integral parts of a healthcare provider’s diagnostic workflow, allowing radiologists and other medical professionals to view, analyze, and interpret medical images such as X-rays, MRIs, and CT scans. The OrthoPACS variant is particularly focused on orthopedic imaging, making the accuracy of measurements in these systems even more vital for patient care outcomes.
The classification of this recall as a Class II action by the FDA indicates that while the defect may cause temporary health problems or pose a serious risk of injury, it is not typically life-threatening in the immediate sense. However, the potential for inaccurate measurements displayed by the software introduces a significant layer of uncertainty into the diagnostic process. For medical professionals relying on these precise figures to make treatment decisions, the recall represents a necessary interruption to ensure patient safety and data reliability. The distribution pattern suggests that healthcare facilities in the aforementioned states should be particularly vigilant in checking their inventory against the specific UDI codes provided.
If you are a healthcare administrator or a medical professional in one of the affected states, it is crucial to verify whether your facility’s Merge PACS or Merge OrthoPACS workstation matches the described software version and UDI code. The recall does not specify the total number of units involved, which means that individual facilities must take proactive steps to identify their own devices. This is not a widespread consumer product recall but a targeted industry-specific action affecting professional medical infrastructure. Understanding the exact nature of the product and its distribution helps in isolating the issue quickly and minimizing disruption to patient care while the remedy is determined.
The hazard, explained
When a medical device like the Merge PACS or Merge OrthoPACS workstation is described as having a "software issue," it can sound abstract and technical. However, the reality of what goes wrong here is quite concrete and directly impacts the accuracy of patient care. In plain terms, the software responsible for displaying diagnostic measurements is failing to calculate or render numbers correctly. This isn't a glitch that causes the screen to freeze or the computer to crash; rather, it is a silent error in data presentation. The system may accept an image file without complaint, process it through its algorithms, and then display a measurement value that does not match the actual physical dimensions of the pathology being viewed.
To understand why this matters, we have to look at how these workstations function. Merge PACS (Picture Archiving and Communication System) and OrthoPACS are specialized computers used by radiologists and orthopedic surgeons to view, store, and analyze medical images such as X-rays, MRIs, and CT scans. A critical part of their job is measuring things within those images—for example, determining the exact size of a bone fracture, the length of a surgical implant needed, or the diameter of a tumor. The software contains specific tools that allow clinicians to draw lines on the screen, which should then translate into accurate millimeter or centimeter readings based on the calibration of the imaging source.
The hazard arises when this translation process breaks down. If the software version V9.5 miscalculates these distances, the number displayed on the screen becomes unreliable. A tumor might appear smaller than it actually is, leading a surgeon to believe less tissue needs to be removed. Conversely, a bone fracture might look larger or more displaced than it is, potentially leading to unnecessary or overly aggressive surgical intervention. In the context of orthopedic imaging, precise measurement is often the difference between a successful recovery and a complication. The software itself does not "hurt" the patient physically; rather, it provides false confidence or false alarm to the medical professional making high-stakes decisions.
This type of hazard is particularly dangerous because it is subtle. There are no warning lights flashing on the console. The image looks sharp, and the interface operates normally. The error is in the metadata—the numbers attached to the visual data—which can easily be overlooked if a clinician relies too heavily on the digital readout without cross-referencing with manual checks or other imaging modalities. For patients, this means that the diagnostic foundation of their treatment plan could be built on inaccurate data, potentially affecting diagnosis accuracy, surgical planning, and ultimately, health outcomes.
Who is most at risk
To understand who is truly at risk in this specific recall, we first need to look past the idea that a "consumer product" might end up in a home kitchen or garage. This is not a defective toaster or a faulty car seat. The products recalled by Merge Healthcare, Inc.—specifically the Merge PACS and Merge OrthoPACS medical imaging diagnostic workstations—are sophisticated pieces of clinical infrastructure. These systems are installed in hospitals, diagnostic imaging centers, orthopedic clinics, and radiology departments across California, Florida, Kentucky, Nebraska, Washington, and Wisconsin. Therefore, the primary group "at risk" is not the general public walking down the street, but rather patients who visit these specific healthcare facilities for X-rays, CT scans, MRIs, or other diagnostic imaging procedures.
The core of the danger lies in what the software does: it displays measurements inaccurately. In a medical context, precision is not just a matter of convenience; it is often a matter of life and death. For patients, this risk manifests when a radiologist or physician relies on these workstations to measure the size of a tumor, the alignment of a broken bone, or the progression of a degenerative joint disease. If the software reports that a lesion is 10 millimeters when it is actually 15 millimeters, the clinical picture is fundamentally distorted. This means that patients are at risk of receiving a diagnosis that is either overly optimistic or unnecessarily alarming, leading to potential delays in treatment or inappropriate medical interventions.
While any patient undergoing imaging could theoretically be affected, certain groups may face heightened consequences from these errors. Elderly patients, who frequently suffer from complex orthopedic issues like hip fractures or severe arthritis, rely heavily on the Merge OrthoPACS system for accurate bone alignment measurements. An error here could lead to improper surgical planning or incorrect prosthetic sizing, resulting in poor recovery outcomes or further injury. Similarly, oncology patients are at significant risk. Cancer treatment plans, including radiation therapy dosages and surgical margins, are often determined by precise volumetric measurements of tumors. Inaccurate data from a Merge PACS workstation could compromise the effectiveness of cancer care, potentially allowing a disease to progress unchecked or exposing healthy tissue to unnecessary radiation.
Furthermore, the risk extends to individuals with rare or ambiguous conditions that require meticulous monitoring over time. For patients whose treatment plans depend on tracking subtle changes in anatomy over months or years, a systematic software error can mask real progress or exaggerate minor fluctuations. This makes it difficult for their doctors to make informed decisions about continuing, pausing, or changing therapies. While the recall notice does not specify which exact models beyond version V9.5 are affected, anyone who has had imaging done at a facility using this specific software configuration between the distribution dates is part of the vulnerable population. It is important to remember that you cannot see this error with your naked eye; the images may look perfectly normal on the screen while containing hidden numerical inaccuracies.
In summary, the individuals most at risk are those who have recently undergone diagnostic imaging at a clinic or hospital in the affected states and used a Merge Healthcare workstation running version V9.5. The risk is not immediate physical harm from an exploding device, but rather the subtle, downstream impact of misdiagnosis or mistreatment based on faulty data. If you fall into this category, your risk is tied to the accuracy of the measurements taken during your visit, which are now called into question by this Class II recall.
How to tell if you have the recalled item
If you are a healthcare provider or work within a radiology department, identifying whether your diagnostic workstation is part of this specific recall requires careful attention to software versions and unique device identifiers. Because Merge Healthcare, Inc. has issued this Class II recall for its Merge PACS and Merge OrthoPACS medical imaging diagnostic workstations, the primary way to confirm if your system is affected is by checking the exact software configuration installed on your machine. This is not a broad recall of every piece of equipment the company has ever sold; it targets a very specific technical setup. Therefore, you must look beyond just the brand name and verify the precise version numbers and UDI codes associated with your installation.
The first and most critical step is to inspect the software version running on your workstation. According to the FDA recall facts, the affected units are those running Merge PACS or Merge OrthoPACS specifically at software version V9.5. If your system is running an earlier update or a later patch that may have addressed this issue (though the remedy is not yet stated), it might not be included in this specific batch. However, you cannot rely on the version number alone. You must also locate and verify the Unique Device Identifier (UDI) embedded in the software metadata. The recalled items are explicitly defined by the following UDI string: (01)00842000101239(10)9.5.0(11)260409. If your system’s configuration matches this exact sequence, it is part of the recalled group.
To find this information, you will need to access the administrative or about section of your diagnostic workstation’s interface. Medical imaging workstations typically display their software build numbers and UDI details in the help menu, system settings, or during the initial boot-up screen. Look for a field labeled "Version," "Build," or "UDI." Write this information down exactly as it appears. Do not guess or approximate the numbers, as even a single digit difference could mean your unit is safe from this particular software defect.
Additionally, consider the distribution pattern to see if your facility falls within the known affected regions. While nationwide distribution is mentioned, the recall facts specifically highlight states where these units have been distributed: California, Florida, Kentucky, Nebraska, and Washington. If your facility is located in Wisconsin (as noted in the state field) or any of the states above, you should exercise extra caution. However, location alone does not confirm the recall; it only indicates a higher probability that your unit might be from this distribution batch. The definitive proof remains the software version V9.5 and the specific UDI code listed above.
- Brand: Merge Healthcare
- Product Line: Merge PACS or Merge OrthoPACS
- Software Version: V9.5
- Specific UDI to Match: (01)00842000101239(10)9.5.0(11)260409
If you cannot find this information on your own, contact your facility’s IT department or the vendor who installed the system. They will have access to the inventory logs and installation records that can quickly confirm whether your workstation matches these precise criteria. Until you verify these details, assume that any Merge PACS or OrthoPACS unit running V9.5 could be part of this recall.
What to do — step by step
If you are a healthcare provider or an institution currently utilizing Merge Healthcare’s diagnostic workstations, specifically the Merge PACS and Merge OrthoPACS systems, it is crucial to address this recall immediately. The primary concern here involves a software defect that may cause measurements to be displayed inaccurately. In a medical context, even minor discrepancies in imaging data can lead to significant diagnostic errors, making prompt action not just a regulatory requirement but a vital patient safety measure. However, there is an important piece of information to clarify right away: the recall notice issued by the FDA on July 22, 2026, does not explicitly state a specific remedy such as a software patch, a repair protocol, or a direct replacement plan at this time. While this silence might feel unsettling, it is common in the early stages of a Class II recall where manufacturers are still finalizing their corrective action plans. Therefore, your immediate goal is to mitigate risk while waiting for official guidance.
First and foremost, you must take steps to prevent any potential harm by pausing the use of the affected software for critical diagnostic measurements. If your facility relies on these workstations for orthopedic or general medical imaging, consider implementing a manual verification process for any measurements taken prior to this date if they are still relevant to ongoing patient care. Do not rely solely on the automated metrics provided by the Merge PACS or Merge OrthoPACS system until you have confirmation that the software issue has been resolved. This is a proactive measure to ensure that no incorrect data influences clinical decisions while the recall process unfolds.
Next, you need to identify exactly which units are involved in this distribution pattern. The recall affects devices with Software version V9.5 and the specific Unique Device Identifier (UDI) of 00842000101239(10)9.5.0(11)260409. Check your inventory logs carefully against these identifiers. Note that while the distribution was nationwide, it specifically included states such as California, Florida, Kentucky, Nebraska, and Washington. If you are located in Wisconsin (WI), where this notice is classified, or if your institution received equipment from the aforementioned states, you are likely within the scope of this recall. Document the serial numbers, installation dates, and current software versions of all affected workstations to streamline future communication.
Since a specific remedy like a return or repair has not yet been detailed in the official facts, your next step is to establish direct contact with Merge Healthcare, Inc. Reach out to their customer support or regulatory affairs department using the contact information provided on their official website or in previous correspondence. Inquire specifically about their timeline for releasing a software update or corrective action. Simultaneously, monitor official FDA recall alerts and news releases from Merge Healthcare for updates. Until you receive explicit instructions to return the device or download a patch, maintain your current operational protocols but with heightened caution regarding the accuracy of displayed measurements. Keep detailed records of all communications with the manufacturer, as these will be essential if a reimbursement or replacement process is initiated later.
Finally, ensure that your IT and clinical teams are aligned on this issue. Conduct a brief internal briefing to inform radiologists and technicians about the potential for inaccurate measurements. This transparency helps maintain trust with patients and ensures that medical professionals remain vigilant during the interim period. While we wait for the manufacturer to define the exact path forward—whether that involves a remote software fix, an in-person service visit, or a full unit replacement—your diligence in identifying the affected units and communicating the risk is the most effective action you can take right now.
Your refund, repair, or replacement options
When you encounter a product recall, the most pressing question is often, "What do I do now?" and "How will my specific situation be resolved?" In this particular case involving Merge Healthcare’s PACS and OrthoPACS medical imaging diagnostic workstations, the official recall notice from the U.S. Food and Drug Administration (FDA) has a notable gap: it does not explicitly state the remedy. This means we do not have confirmed details on whether you will receive a refund, a software patch to fix the measurement inaccuracies, or a hardware replacement. While this silence can feel unsettling, it is actually quite common in the early stages of a Class II recall, particularly for complex medical software systems. The absence of a stated remedy does not mean the issue is being ignored; rather, it often indicates that the manufacturer is still finalizing the technical solution or coordinating with healthcare providers to determine the most effective path forward.
Because this is a Class II recall, which involves products that might cause temporary health problems or pose a slight threat of serious injury, the FDA takes these matters seriously. However, the lack of a public remedy plan suggests that the resolution process may be handled directly between Merge Healthcare and the specific medical facilities or institutions that purchased the affected units. If you are an individual patient who owns one of these workstations personally—which is highly unlikely given that these are professional-grade diagnostic tools used in clinical settings—you would need to reach out directly to Merge Healthcare for guidance. For healthcare professionals, your first step should be to check your original purchase order or contact your medical equipment vendor. They often have dedicated support channels that receive update notifications before they are published broadly.
If you are a hospital administrator or IT director responsible for these systems, do not wait for a public announcement if you suspect your installation is affected. The recall description specifies software version V9.5 with the Unique Device Identifier (UDI) ending in 260409. You should immediately verify this UDI on your system’s configuration screen. If it matches, contact Merge Healthcare’s technical support team directly using the contact information provided in your original service contract or user manual. Do not rely solely on general public hotlines, as enterprise software recalls often require specific serial number verification to ensure you receive the correct patch or update.
In the meantime, since the hazard involves inaccurate measurements which could lead to misdiagnosis, it is prudent to cross-verify any critical imaging data using a secondary, unaffected system if available. While we cannot offer a refund or replacement at this moment, staying informed is your best defense. Keep an eye on the FDA’s official recall database and Merge Healthcare’s newsroom for updates. When the remedy is announced, it will likely involve a software update to correct the measurement display issue, which is the standard resolution for this type of defect. Until then, maintain clear records of your system’s version and UDI to streamline the process once details are released.
What can happen if you ignore it
When a medical diagnostic tool like the Merge PACS or Merge OrthoPACS workstation displays inaccurate measurements, the consequences are not merely technical glitches; they directly impact clinical judgment and patient care. Because these workstations are used to interpret critical imaging data, relying on faulty software can lead to significant errors in diagnosis. If the software misrepresents the size of a lesion, the alignment of a bone fracture, or the dimensions of an organ, a healthcare provider may make decisions based on false information. This is not just about a wrong number on a screen; it is about the potential for a cascade of medical errors that could affect treatment plans, surgical interventions, or the decision to pursue further testing.
The primary risk lies in the subtle nature of the error. Inaccurate measurements might not always be obvious to the naked eye without direct comparison to known standards or raw data. A radiologist or orthopedic specialist might proceed with a treatment plan assuming a specific dimension that does not actually exist. For example, if a tumor is measured as smaller than it truly is due to software distortion, a surgeon might choose a less aggressive approach than necessary, potentially leaving residual disease behind. Conversely, if a benign structure is measured as larger or more irregular than it is, a patient might undergo unnecessary invasive procedures, exposing them to risks that could have been avoided with accurate data.
While the official recall notice does not list specific reports of injuries or adverse events at this time, the potential for harm in medical diagnostics is inherently serious. The absence of reported incidents does not mean the risk is zero; it often means that errors are caught later through other diagnostic methods or follow-up visits. However, ignoring a known software defect delays the correction of that defect. Each day the software remains unpatched or replaced is another day where inaccurate data could influence a patient’s health outcome. In urgent care settings or when monitoring chronic conditions over time, consistent inaccuracy can lead to mismanagement of disease progression, making it difficult for providers to track whether a treatment is actually working.
- Misdiagnosis: Incorrect measurements can lead to false positives or false negatives, causing patients to be told they are healthy when they are not, or vice versa.
- Treatment Delays: If the initial diagnosis is flawed due to inaccurate data, it may take longer to arrive at the correct conclusion, delaying critical care.
- Unnecessary Procedures: Overestimation of size or severity can lead to surgeries or biopsies that were not medically required, increasing patient anxiety and healthcare costs.
- Erosion of Trust: Repeated issues with diagnostic tools can undermine the confidence patients and providers place in medical imaging technologies.
It is crucial to understand that this hazard is specific to the software version V9.5 identified in the recall. The issue is not necessarily with the hardware itself, but with how the data is processed and displayed. Continuing to use this specific configuration without addressing the recall means continuing to operate with a known vulnerability in your diagnostic accuracy. While general safety practices suggest that all medical devices should be maintained up to date, ignoring a Class II recall for a diagnostic workstation is particularly risky because it affects the foundational data used for making life-altering health decisions.